Sitosterolemia is a rare hereditary disorder of lipid metabolism, of autosomal recessive inheritance, characterized by the abnormal accumulation of plant sterols in blood and tissues. It is caused by pathogenic variants in ABCG5 or ABCG8, genes that encode an intestinal and hepatic transporter responsible for limiting the absorption and promoting the biliary elimination of these compounds.
Sitosterolemia
The ABCG5 and ABCG8 genes encode the sterolin-1 and sterolin-2 proteins, which function together as a transporter heterodimer in the small intestine and liver. Under normal conditions, this complex expels phytosterols back into the intestinal lumen and facilitates their secretion into bile, preventing plant sterols such as sitosterol, campesterol, or stigmasterol from accumulating in the body.
When biallelic pathogenic variants affecting ABCG5 or ABCG8 exist, the transporter becomes less effective, leading to excessive intestinal absorption and insufficient biliary elimination of phytosterols. Consequently, these compounds accumulate in plasma and tissues, potentially causing xanthomas, hematological involvement, and premature atherosclerosis. The disease is inherited in an autosomal recessive pattern; therefore, an affected individual usually inherits two altered copies related to one of these genes, one from each parent. It is a very rare and likely underdiagnosed condition, with over a hundred cases described and some recurrent variants in specific populations, such as certain Asian groups or Amish communities.
Symptoms
The clinical presentation is highly variable. It can begin in childhood with marked hypercholesterolemia or tendinous and tuberous xanthomas, but it can also be diagnosed in adulthood or remain largely asymptomatic for years. The main findings include xanthomas, arthralgias or arthritis, splenomegaly, and hematological alterations such as hemolytic anemia, stomatocytosis, and macrotrombocytopenia. The most important complication is premature atherosclerosis, which can cause coronary heart disease, valvular involvement, myocardial infarction, or sudden death if the disease is not adequately recognized and treated.
Disease management
The management of sitosterolemia is effective if established early and focuses on reducing the phytosterol load. The basis of treatment is a diet low in plant sterols, especially avoiding products enriched with sterols or stanols, vegetable oils, nuts, seeds, avocado, and other foods very rich in these compounds. The pharmacological treatment of choice is ezetimibe, which inhibits intestinal absorption of sterols and significantly reduces plasma sitosterol concentrations. In cases with incomplete response, bile acid sequestrants may be added, while statins alone do not correct the main defect. Follow-up includes monitoring of phytosterols, lipid profile, complete blood count, liver function, and cardiovascular evaluation.
Genes analyzed
Bibliography
Myrie SB, Steiner RD, Mymin D. Sitosterolemia. 2013 Apr 4 [updated 2020 Jul 16]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
Tada H, Nomura A, Ogura M, et al. Diagnosis and Management of Sitosterolemia 2021. J Atheroscler Thromb. 2021 Aug 1;28(8):791-801.
Liebeskind A, Peterson AL, Wilson D. Sitosterolemia. 2023 Mar 10. In: Feingold KR, Adler RA, Ahmed SF, Anawalt B, Blackman MR, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hamilton E, Hofland J, Jan de Beur S, Kalra S, Kaltsas G, Kapoor N, Kim M, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung B, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–.
Peterson AL, DeLine J, Korcarz CE, et al. Phenotypic Variability in Atherosclerosis Burden in an Old-Order Amish Family With Homozygous Sitosterolemia. JACC Case Rep. 2020 Apr 15;2(4):646-650.
